EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

Audion Therapeutics and REGAIN Consortium Announce Positive Phase I Results in Patients with Sensorineural Hearing Loss

AMSTERDAM, The Netherlands, February 05, 2019 / -- The REGAIN consortium, led by Audion Therapeutics BV, a company dedicated to the development of the...
Continue Reading →
news

Orion and Bayer jointly present new data in prostate cancer from the Darolutamide ARAMIS -study

First presentation of data from the pivotal Phase III ARAMIS trial with the investigational compound darolutamide in patients with advanced prostate cancer that has ...
Continue Reading →
Europe

Sharp enhances IRT solution with latest investment

Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has announced a $650,000 investment into enhancing its Intera...
Continue Reading →
Europe

CRF Bracket Becomes a Leading Employer in Romania Two Years after Establishing Office as Demand for Trustworthy Global Support of eClinical Solutions Continues to Grow

Plymouth Meeting, PA – February 6, 2019:  CRF Bracket is celebrating unprecedented success in Romania after opening an eClinical technology facility in the...
Continue Reading →
Europe

FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)

First medicine approved in the U.S. specifically for the treatment of aTTP, a rare blood-clotting disorderCablivi is the first U.S. approval for Sanofi's new rare bl...
Continue Reading →
news

From Patient-Centric Technologies to Clinical Trial Supply Chain Management, CRF Bracket Moves Clinical Trials Forward at the 10th Annual SCOPE Summit

Subject matter experts from CRF Bracket take an active thought-leadership role with key presentations and interactive roundtables at the conference Plymouth Meetin...
Continue Reading →
Asia Pacific

Development progress in 2018 for acute ischemic stroke drugs will fuel market growth, says GlobalData

Activase (alteplase) is currently the only FDA-approved drug available for the treatment of acute ischemic stroke (AIS) in the 8MM*; however, novel drugs designed to...
Continue Reading →
Asia Pacific

Brand new type of cancer drug has potential to fill unmet needs in oncology market, says GlobalData

Following a study published in The Lancet Oncology regarding a brand new type of cancer drug that has shown promise in multiple cancer types in early Phase I/II tria...
Continue Reading →
Europe

4 of the Top 7 Global CROs Have Selected Veeva Vault eTMF as Their Enterprise Standard

BARCELONA, Spain — 13 February 2019 — Veeva Systems (NYSE:VEEV) today announced four of the world’s top seven largest CROs are standardizing on V...
Continue Reading →
Europe

SGS to Conduct its First Malaria Human Challenge Trial in Belgium

Antwerp, Belgium, February 12, 2019 SGS, a leading life-sciences, clinical and bioanalytical contract solutions provider, today announced that it will commence ...
Continue Reading →
Quotient